Chemical activators of OTTMUSG00000010009 employ various biochemical mechanisms to modulate intracellular signaling pathways, ultimately resulting in the phosphorylation and activation of this specific protein. Forskolin, for instance, bypasses membrane-bound receptors and directly stimulates adenylate cyclase, thereby increasing the concentration of cyclic AMP (cAMP) within the cell. This rise in cAMP subsequently activates protein kinase A (PKA), which then targets and phosphorylates OTTMUSG00000010009. Similarly, Isoproterenol, a beta-adrenergic agonist, binds to beta receptors and brings about the activation of adenylate cyclase, leading to an increase in cAMP and activation of PKA. Once activated, PKA phosphorylates OTTMUSG00000010009. Analogous cAMP-mediated activation is achieved by cell-permeable cAMP analogs like Dibutyryl-cAMP and Bromo-cAMP, which diffuse into cells and activate PKA, leading to the phosphorylation of the protein.
In addition to the cAMP-PKA axis, other pathways also participate in modulating the activity of OTTMUSG00000010009. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which phosphorylates a plethora of substrates, including OTTMUSG00000010009. Ionomycin, by increasing intracellular calcium levels, can activate calcium-dependent kinases capable of phosphorylating OTTMUSG00000010009. BAY K8644 facilitates calcium influx through L-type calcium channels, thereby activating calcium-dependent protein kinases that may target OTTMUSG00000010009. The activation of stress-activated protein kinases (SAPKs) by Anisomycin and the inhibition of protein phosphatases by Okadaic Acid both lead to an increase in phosphorylation events within the cell, which, in turn, can lead to the phosphorylation and activation of OTTMUSG00000010009. Thapsigargin, by inhibiting SERCA, raises intracellular calcium levels, potentially leading to the activation of kinases that phosphorylate OTTMUSG00000010009. Vasoactive Intestinal Peptide (VIP) works through G-protein-coupled receptors to elevate cAMP and activate PKA, which can also phosphorylate OTTMUSG00000010009. Lastly, Fusicoccin stabilizes the interaction between H+-ATPases and 14-3-3 proteins, which may trigger a kinase signaling cascade culminating in the phosphorylation of OTTMUSG00000010009. Each of these chemical activators, through their unique mechanisms, ensures that OTTMUSG00000010009 is phosphorylated and thereby activated.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, binds to beta receptors, causing a rise in intracellular cAMP, which activates PKA. PKA then phosphorylates and activates OTTMUSG00000010009. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which phosphorylates numerous substrates that can include OTTMUSG00000010009, resulting in its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, leading to the activation of calcium-dependent kinases that can phosphorylate and activate OTTMUSG00000010009. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
BAY K8644 is an L-type calcium channel agonist that increases calcium influx, which activates calcium-dependent protein kinases potentially resulting in the phosphorylation and activation of OTTMUSG00000010009. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases (SAPKs), leading to phosphorylation of various substrates including OTTMUSG00000010009, thereby activating it. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) and thereby raises intracellular calcium levels, which can lead to the activation of calcium-dependent kinases that phosphorylate and activate OTTMUSG00000010009. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases PP1 and PP2A, maintaining proteins in a phosphorylated state. This inhibition can lead to the persistent activation of kinases that phosphorylate OTTMUSG00000010009. | ||||||
Calcium dibutyryladenosine cyclophosphate | 362-74-3 | sc-482205 | 25 mg | $147.00 | ||
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA. Activated PKA can phosphorylate and thus activate OTTMUSG00000010009. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
Bromo-cAMP, another cell-permeable cAMP analog, activates PKA, which in turn can phosphorylate and activate OTTMUSG00000010009. | ||||||
Oridonin, R. rubescens | 28957-04-2 | sc-202751 | 5 mg | $77.00 | ||
Fusicoccin stabilizes the interaction between H+-ATPases and 14-3-3 proteins, potentially triggering a kinase signaling cascade that could lead to the phosphorylation and subsequent activation of OTTMUSG00000010009. | ||||||